日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimizing In Vivo CAR T-cell Engineering for Cancer Immunotherapy

优化体内CAR-T细胞工程以用于癌症免疫治疗

Wang, Ruiheng; Yu, Jianhua; Caligiuri, Michael A; Ma, Shoubao

Human type-1 innate lymphoid cells control leukemia stem cell differentiation and limit acute myeloid leukemia development

人类1型固有淋巴细胞控制白血病干细胞分化并限制急性髓系白血病的发展。

Li, Zhenlong; Ma, Rui; Tang, Hejun; Liu, Ningyuan; Zhang, Jianying; Marcucci, Guido; Caligiuri, Michael A; Yu, Jianhua

Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease

EBV BGLF4 的表观遗传激活决定 EBV 阳性中枢神经系统淋巴增生性疾病的抗病毒治疗方案反应。

Weigel, Christoph; Klimaszewski, Haley L; Tounkara, Fode; Addissie, Selamawit; Schlotter, Sarah; Pray, Betsy; Dugan, James P; Haverkos, Bradley M; Villagomez, Lynda; Lustberg, Mark; Porcu, Pierluigi; Voorhees, Timothy; Ambinder, Richard F; Kenney, Shannon C; Fingeroth, Joyce; Delecluse, Henri-Jacques; Caligiuri, Michael A; Alinari, Lapo; Bumgardner, Ginny; Oakes, Christopher C; Baiocchi, Robert A

Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy

YTHDF2 的缺失增强了 Th9 细胞的编程和 CAR-Th9 细胞的抗肿瘤疗效

Xiao, Sai; Duan, Songqi; Hong, Yaqun; Zhang, Jianying; Ma, Shoubao; Caligiuri, Michael A; Yu, Jianhua

Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice

表达抗PSCA CAR和IL-15的现成不变型NKT细胞可促进小鼠胰腺癌消退

Dai, Zhenyu; Zhu, Zheng; Li, Zhiyao; Tian, Lei; Teng, Kun-Yu; Chen, Hanyu; Wang, Li-Shu; Zhang, Jianying; Melstrom, Laleh; Caligiuri, Michael A; Yu, Jianhua

CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors.

靶向 CD155 的 CAR-T 细胞可降低白血病和实体瘤临床前模型中的肿瘤负荷

Xiong Tianchen, Wang Ge, Yu Peng, Li Zhenlong, Li Debao, Zhang Jianying, Lu Song, Yang Ruiqi, Lian Xiaolong, Mi Jianhong, Ma Rui, Li Zhiyao, Marcucci Guido, Zhao Tingting, Caligiuri Michael A, Yu Jianhua

Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer

PSCA CAR 工程化 Vδ1 γδ T 细胞在胰腺癌免疫治疗中的疗效和安全性比较

Li, Zhixin; Liu, Ningyuan; Shah, Zahir; Jin, Lewei; Tian, Lei; Sun, Xiaolei; Zhang, Jianying; Li, Zhiyao; Caligiuri, Michael A; Yu, Jianhua

Natural killer cell-based immunotherapy for cancer

基于自然杀伤细胞的癌症免疫疗法

Ma, Shoubao; Yu, Jianhua; Caligiuri, Michael A

The emerging field of oncolytic virus-based cancer immunotherapy

基于溶瘤病毒的癌症免疫疗法这一新兴领域

Ma, Rui; Li, Zhenlong; Chiocca, E Antonio; Caligiuri, Michael A; Yu, Jianhua

Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic leukemia.

IL-15 产生型自然杀伤细胞在 B 细胞急性淋巴细胞白血病中发挥治疗作用的根本原因在于 I 型干扰素产生的内在抑制

Kumar Anil, Taghi Khani Adeleh, Duault Caroline, Aramburo Soraya, Sanchez Ortiz Ashly, Lee Sung June, Chan Anthony, McDonald Tinisha, Huang Min, Lacayo Norman J, Sakamoto Kathleen M, Yu Jianhua, Hurtz Christian, Carroll Martin, Tasian Sarah K, Ghoda Lucy, Marcucci Guido, Gu Zhaohui, Rosen Steven T, Armenian Saro, Izraeli Shai, Chen Chun-Wei, Caligiuri Michael A, Forman Stephen J, Maecker Holden T, Swaminathan Srividya